531 related articles for article (PubMed ID: 31317666)
1. Long non-coding RNA H19 is responsible for the progression of lung adenocarcinoma by mediating methylation-dependent repression of CDH1 promoter.
Gao LM; Xu SF; Zheng Y; Wang P; Zhang L; Shi SS; Wu T; Li Y; Zhao J; Tian Q; Yin XB; Zheng L
J Cell Mol Med; 2019 Sep; 23(9):6411-6428. PubMed ID: 31317666
[TBL] [Abstract][Full Text] [Related]
2. lncRNA H19 promotes viability and epithelial-mesenchymal transition of lung adenocarcinoma cells by targeting miR-29b-3p and modifying STAT3.
Liu L; Liu L; Lu S
Int J Oncol; 2019 Mar; 54(3):929-941. PubMed ID: 30747209
[TBL] [Abstract][Full Text] [Related]
3. LncRNA TRERNA1 facilitates hepatocellular carcinoma metastasis by dimethylating H3K9 in the CDH1 promoter region via the recruitment of the EHMT2/SNAI1 complex.
Song W; Gu Y; Lu S; Wu H; Cheng Z; Hu J; Qian Y; Zheng Y; Fan H
Cell Prolif; 2019 Jul; 52(4):e12621. PubMed ID: 31012192
[TBL] [Abstract][Full Text] [Related]
4. The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma.
Li CF; Li YC; Wang Y; Sun LB
Cell Physiol Biochem; 2018; 50(1):196-213. PubMed ID: 30278464
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
6. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
[TBL] [Abstract][Full Text] [Related]
7. LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway.
Yan SP; Chu DX; Qiu HF; Xie Y; Wang CF; Zhang JY; Li WC; Guo RX
J Cell Mol Med; 2019 Apr; 23(4):2656-2666. PubMed ID: 30697971
[TBL] [Abstract][Full Text] [Related]
8. LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma.
Hou XM; Yuan SQ; Zhao D; Liu XJ; Wu XA
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509961
[TBL] [Abstract][Full Text] [Related]
9. LncRNA H19 promotes epithelial-mesenchymal transition (EMT) by targeting miR-484 in human lung cancer cells.
Zhang Q; Li X; Li X; Li X; Chen Z
J Cell Biochem; 2018 Jun; 119(6):4447-4457. PubMed ID: 29219208
[TBL] [Abstract][Full Text] [Related]
10. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5.
Jia Y; Duan Y; Liu T; Wang X; Lv W; Wang M; Wang J; Liu L
Cell Death Dis; 2019 Jul; 10(8):573. PubMed ID: 31363080
[TBL] [Abstract][Full Text] [Related]
11. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.
Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y
Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539
[TBL] [Abstract][Full Text] [Related]
12. MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines.
Terashima M; Tange S; Ishimura A; Suzuki T
J Biol Chem; 2017 Jan; 292(1):82-99. PubMed ID: 27852821
[TBL] [Abstract][Full Text] [Related]
13.
Terashima M; Ishimura A; Wanna-Udom S; Suzuki T
J Biol Chem; 2018 Nov; 293(47):18016-18030. PubMed ID: 30262664
[TBL] [Abstract][Full Text] [Related]
14. LncRNA-SNHG7 regulates proliferation, apoptosis and invasion of bladder cancer cells assurance guidelines.
Zhong X; Long Z; Wu S; Xiao M; Hu W
J BUON; 2018; 23(3):776-781. PubMed ID: 30003751
[TBL] [Abstract][Full Text] [Related]
15. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA highly up-regulated in liver cancer promotes epithelial-to-mesenchymal transition process in oral squamous cell carcinoma.
Su W; Tang J; Wang Y; Sun S; Shen Y; Yang H
J Cell Mol Med; 2019 Apr; 23(4):2645-2655. PubMed ID: 30677230
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
[TBL] [Abstract][Full Text] [Related]
18. Correlation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinoma.
Wang Q; Cheng N; Li X; Pan H; Li C; Ren S; Su C; Cai W; Zhao C; Zhang L; Zhou C
Oncotarget; 2017 Jan; 8(2):2558-2567. PubMed ID: 27911863
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1.
Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C
J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890
[TBL] [Abstract][Full Text] [Related]
20. The long non-coding RNA SNHG1 promotes bladder cancer progression by interacting with miR-143-3p and EZH2.
Xiang W; Lyu L; Huang T; Zheng F; Yuan J; Zhang C; Jiang G
J Cell Mol Med; 2020 Oct; 24(20):11858-11873. PubMed ID: 32885590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
